EUROMEDICA 

Hanover

6-7  Juni 2008

Advanced methods of diagnosis,
treatment and prophylactics

European Academy of Natural Sciences, Hanover

European Scientific Society, Hanover

Russian Academy of Natural Sciences, Moscow


O.V. Timofeeva
V.A. Groysman
V.N. Chernova
O.S. Vitchenko
E.V. Telenkova
E.A. Ablaeva
Zh.A. Melnikova
A.S. Sorokin
SHOCK WAVE THERAPY AS A PROMISING TECHNIQUE IN CARDIAC REHABILITATION
Cardiology Department, Municipal Clinical Hospital No.1, Togliatti, Russia

Nowadays the onrush of cardiology as a branch of medicine is caused not only by the breakthrough in science intensive technologies, but also by the growing society need in adequate influence over pathogenetic processes which invoke the cardiovascular diseases. In daily practice cardiologists deal mainly with patients suffering from ischemic heart disease. According to researches the cardiovascular death rate among people suffering from stenocardia has amounted to 5,5% among men and to 3,8% among women. The main aim of the medical treatment for stenocardia is the improvement of life quality by means of the decrease in coronary pain attacks, decrease of nitrate demand, increase of physical exercises endurance and prophylaxis of acute myocardial infarction development and cardiac insufficiency. To achieve a permanent improvement of life quality for a patient it is not enough to affect the leading section of chronic myocardial ischemia pathogeny via available methods such as pharmacotherapy, percutaneous coronary intervention (angioplasty) with stent implantation or coronary artery bypass graft. The patient is constantly being a subject to medical treatment with frequent preparation overdosing and repeated invasions of the disease. All the above mentioned along with adverse reactions to pharmacotherapy and postoperative complications after invasion methods urge to look for new ways of treatment for various stenocardia forms. During the Cardiology World Congress 2006 a group of Swiss scientists published the first placebo controlled trial preliminary results of shock wave therapy for stable stenocardia rehabilitation. The efficiency of the new treatment method was clearly revealed after testing it on a group of patients. The main aim of the method is the anginaneogenesis provocation in cardiac muscle problem areas, which leads to significant perfusion improvement. It is achieved by low-frequency ultrasound application according to a definite therapeutic regimen. The results of the therapy are evaluated in 6 months via clinic laboratory and functional methods and also via SPECT-imaging. In Russia only scant information on the shock wave therapy application is available. The new method was implemented since December 2007, taking into account the world’s positive experience in shock wave therapy application for patients with ischemic heart disease on the basis of the cardiological department of Togliatti “Municipal Clinical Hospital No.1” with assistance of the Swiss specialists. By our Swiss colleagues who were the originators of the development of shock wave therapy in cardiology the personnel of the hospital was thought to work with the equipment,. In Russian Federation “Municipal Clinical Hospital No.1” is among the first to start application of this new method in clinical practice. Insignificant experience of the shock wave therapy application in our conditions (by now 12 patients have completed the course of treatment) allow us to talk about high tolerability of the treatment. Up to the present moment there was no evidence of recrudescence and the patients note the positive influence of the treatment. We intent to register the objective evaluation of the treatment quality after the treatment course completion in 6 months. We also intent to publish our practical results in medical periodicals as our Municipal Clinical Hospital No.1 experience in shock wave therapy application continue to grow. We are convinced that the shock wave therapy method of treating patients with ischemic heart disease will secure its footing in treatment along with angioplasty and stent implantation.